United States · Funded startup

Who invested in Evolus

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$150Mraised across 1 round since 2025, from 1 source

Latest round
Debt, $150MMay 2025
Investors
0
See who backed them

The rounds

  1. May 2025
    Debt$150M

    No investor was named in the report.

    Source recorded

Founders and team

From the SEC filings it signed: 4 on the team.

  • David MoatazediExecutive Officer, Directori
  • Lauren SilvernailExecutive Officeri
  • Michael JafarExecutive Officeri
  • Rui AvelarExecutive Officeri

On the board, as filediDavid GillKarah ParschauerPeter FarrellRobert HaymanSimone BlankVikram Malik

Also claim to have backed them

This firm lists Evolus as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Strathspey CrownGrowth equityPer its own site

Quick answers about Evolus

How much has Evolus raised?

Evolus has raised $150M across 1 round since 2025.

When did Evolus last raise?

Evolus's most recent round was a Debt of $150M in May 2025.

What was Evolus's biggest round?

Its most recent round, $150M in May 2025, is also its largest on record.

What stage is Evolus at?

Evolus's latest named round is a Debt, in May 2025.

Where is Evolus based?

Evolus is based in the United States.

Companies like Evolus

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.